338 related articles for article (PubMed ID: 17081598)
1. Modified HPV16 E7/HSP70 DNA vaccine with high safety and enhanced cellular immunity represses murine lung metastatic tumors with downregulated expression of MHC class I molecules.
Li H; Ou X; Xiong J
Gynecol Oncol; 2007 Mar; 104(3):564-71. PubMed ID: 17081598
[TBL] [Abstract][Full Text] [Related]
2. Combined immunization with fusion genes of mutated E7 gene of human papillomavirus type 16 did not enhance antitumor effect.
Pokorná D; Macková J; Dusková M; Rittich S; Ludvíková V; Smahel M
J Gene Med; 2005 Jun; 7(6):696-707. PubMed ID: 15712328
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen.
Hsu KF; Hung CF; Cheng WF; He L; Slater LA; Ling M; Wu TC
Gene Ther; 2001 Mar; 8(5):376-83. PubMed ID: 11313814
[TBL] [Abstract][Full Text] [Related]
4. DNA vaccine encoding heat shock protein 60 co-linked to HPV16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens.
Huang CY; Chen CA; Lee CN; Chang MC; Su YN; Lin YC; Hsieh CY; Cheng WF
Gynecol Oncol; 2007 Dec; 107(3):404-12. PubMed ID: 17905417
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene.
Chen CH; Wang TL; Hung CF; Yang Y; Young RA; Pardoll DM; Wu TC
Cancer Res; 2000 Feb; 60(4):1035-42. PubMed ID: 10706121
[TBL] [Abstract][Full Text] [Related]
6. DNA vaccines against HPV-16 E7-expressing tumour cells.
De Marco F; Hallez S; Brulet JM; Gesché F; Marzano P; Flamini S; Marcante ML; Venuti A
Anticancer Res; 2003; 23(2B):1449-54. PubMed ID: 12820408
[TBL] [Abstract][Full Text] [Related]
7. Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy.
Li Y; Subjeck J; Yang G; Repasky E; Wang XY
Vaccine; 2006 Jun; 24(25):5360-70. PubMed ID: 16714072
[TBL] [Abstract][Full Text] [Related]
8. A DNA vaccine constructed with human papillomavirus type 16 (HPV16) E7 and E6 genes induced specific immune responses.
Yan Q; Cheung YK; Cheng SC; Wang XH; Shi M; Hu MH; Yong X
Gynecol Oncol; 2007 Jan; 104(1):199-206. PubMed ID: 17049969
[TBL] [Abstract][Full Text] [Related]
9. Gene gun administration of therapeutic HPV DNA vaccination restores the efficacy of prolonged defrosted viral based vaccine.
Lin CT; Yen CF; Shaw SW; Yen TC; Chen YJ; Soong YK; Lai CH
Vaccine; 2009 Dec; 27(52):7352-8. PubMed ID: 19781679
[TBL] [Abstract][Full Text] [Related]
10. Recombined DNA vaccines encoding calreticulin linked to HPV6bE7 enhance immune response and inhibit angiogenic activity in B16 melanoma mouse model expressing HPV 6bE7 antigen.
Zhao KJ; Cheng H; Zhu KJ; Xu Y; Chen ML; Zhang X; Song T; Ye J; Wang Q; Chen DF
Arch Dermatol Res; 2006 Jul; 298(2):64-72. PubMed ID: 16710741
[TBL] [Abstract][Full Text] [Related]
11. CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination.
Cheng WF; Hung CF; Lin KY; Ling M; Juang J; He L; Lin CT; Wu TC
Gene Ther; 2003 Aug; 10(16):1311-20. PubMed ID: 12883527
[TBL] [Abstract][Full Text] [Related]
12. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.
Ohlschläger P; Pes M; Osen W; Dürst M; Schneider A; Gissmann L; Kaufmann AM
Vaccine; 2006 Apr; 24(15):2880-93. PubMed ID: 16472545
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccine encoding endosome-targeted human papillomavirus type 16 E7 protein generates CD4+ T cell-dependent protection.
Brulet JM; Maudoux F; Thomas S; Thielemans K; Burny A; Leo O; Bex F; Hallez S
Eur J Immunol; 2007 Feb; 37(2):376-84. PubMed ID: 17274002
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 16 E7 peptide(38-61) linked with an immunoglobulin G fragment provides protective immunity in mice.
Qin Y; Wang XH; Cui HL; Cheung YK; Hu MH; Zhu SG; Xie Y
Gynecol Oncol; 2005 Feb; 96(2):475-83. PubMed ID: 15661238
[TBL] [Abstract][Full Text] [Related]
15. Comparison of HPV DNA vaccines employing intracellular targeting strategies.
Kim JW; Hung CF; Juang J; He L; Kim TW; Armstrong DK; Pai SI; Chen PJ; Lin CT; Boyd DA; Wu TC
Gene Ther; 2004 Jun; 11(12):1011-8. PubMed ID: 14985791
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of immunogenicity of HPV16 E7 oncogene by fusion with E. coli beta-glucuronidase.
Smahel M; Pokorná D; Macková J; Vlasák J
J Gene Med; 2004 Oct; 6(10):1092-101. PubMed ID: 15386741
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of T cell-mediated and humoral immunity of beta-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein.
Smahel M; Poláková I; Pokorná D; Ludvíková V; Dusková M; Vlasák J
Int J Oncol; 2008 Jul; 33(1):93-101. PubMed ID: 18575754
[TBL] [Abstract][Full Text] [Related]
19. Secretory heat-shock protein as a dendritic cell-targeting molecule: a new strategy to enhance the potency of genetic vaccines.
Hauser H; Shen L; Gu QL; Krueger S; Chen SY
Gene Ther; 2004 Jun; 11(11):924-32. PubMed ID: 15085173
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic, therapeutic and anti-metastatic effects of an HPV-16mE6Delta/mE7/TBhsp70Delta fusion protein vaccine in an animal model.
Qian X; Lu Y; Liu Q; Chen K; Zhao Q; Song J
Immunol Lett; 2006 Feb; 102(2):191-201. PubMed ID: 16242781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
